Ryvu Therapeutics S.A. (WSE:RVU)
25.00
-0.95 (-3.66%)
Mar 3, 2026, 5:04 PM CET
12.61% (1Y)
| Market Cap | 578.00M |
| Revenue (ttm) | 90.41M |
| Net Income (ttm) | -118.69M |
| Shares Out | 23.12M |
| EPS (ttm) | -5.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 38,783 |
| Average Volume | 23,371 |
| Open | 26.00 |
| Previous Close | 25.95 |
| Day's Range | 24.50 - 26.00 |
| 52-Week Range | 17.62 - 36.00 |
| Beta | 0.50 |
| RSI | 43.64 |
| Earnings Date | Mar 19, 2026 |